Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Un-audited Result for half year ended 30th September, 2026.

(1D Chandra Bhagat Pharma Limited Date: 07/11/2026 The Listing Manager, Corporate Compliance Department BSE Limited, Phiroze Jeejeebhoy Tower Dalal Street, Mumbai-400001 Scrip Code: (BSE-542934) Sub:- Intimation of Board Meeting held on Friday, 13t November, 2026 pursuant to the Regulation 29 & 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015 (“Listing Regulation”). Dear Sir/Madam, Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of Chandra Bhagat Pharma Limited is scheduled to be held on Friday, 13th November, 2026 at 04:00 P.M. at the Registered Office of the Company, inter alia, to consider and approve the Un-audited Financial Results of the Company for the half year ended 30th September, 2026. Further, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company shall remain closed for all Directors, Key Managerial Personnel, Designated Employees and Connected Persons and shall reopen 48 hours after the declaration of the aforesaid financial results. Kindly take the above on record and inform all those concerned accordingly. Yours Sincerely, FOR CHANDRA BHAGAT PHARMA LIMITED HEMANT C BHAGAT Director DIN: 00233530 Regd. Office : 323 - F, Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai - 400019, Maharashtra, India. CIN L24230MH2003PLC 139534 Tel No. 022 - 24146154 Mobile No. 91+ 9930004507 Email : business@cbcpharma.com Website : www.chcpharma.com